Am Heart J

1. WONG JA, Conen D, Doumouras A, Van Reekum E, et al
   Rationale, Design, and Experiences from the Vanguard Phase of the Bariatric Surgery for the Reduction of Cardiovascular Events (BRAVE) Trial.
   Am Heart J. 2026 Jul 25:107544. doi: 10.1016/j.ahj.2026.107544.
   

   >> Share

   
   

   
   Am J Epidemiol

2. SORBYE LM, Nilsen RM, Klungsoyr K, Morken NH, et al
   Gestational Diabetes Mellitus in Second Pregnancy by Adverse Outcomes of First Pregnancy: a Population-based Historical Cohort Study.
   Am J Epidemiol. 2026 Sep 8:kwag213. doi: 10.1093.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

3. IMRAN M, Ahmad Khan MK, Hussain A, Sherzodbek T, et al
   Comparative antidiabetic effects of Cymbopogon citratus leaf extract, derived silver nanoparticles, and their combination in alloxan-induced diabetic mice.
   Biochem Biophys Res Commun. 2026;835:154537.
   

   >> Share

   
   
4. DKHARGATPHOH BF, Ramesh A, Prabhakar PS, Kumar M, et al
   Synthesis, and biological evaluation of novel 4-thiazolidinone derivatives as promising antidiabetic agents: In silico and in vivo investigations.
   Biochem Biophys Res Commun. 2026;834:154436.
   

   >> Share

   
   

   
   BMC Ophthalmol

5. WOLF S, Michelson G
   Association between macular edema area on optical coherence tomography and Amsler grid sensitivity in diabetic macular edema: a cross-sectional study.
   BMC Ophthalmol. 2026;26:549.
   

   >> Share

   
   

   
   BMJ

6. LIANG J, Choi Y, Shen P, Wells S, et al
   Simultaneous derivation, validation, and comparison of predictor hazard ratios for cardiovascular risk prediction equations in patients with diabetes from high versus non-high income countries: cohort study.
   BMJ. 2026;394:e100535.
   

   >> Share

   
   

   
   Diabet Med

7. GUO Y, Jiao J, Zheng X
   Long non-coding RNA GAS5 binds to miR-137 and regulates Nrf2 to ameliorate insulin resistance in adipose tissue in gestational diabetes mellitus.
   Diabet Med. 2026 Sep 4:e70451. doi: 10.1111/dme.70451.
   

   >> Share

   
   
8. SOLA C, Kokla M, von Zezschwitz J, Nicholas C, et al
   Underrepresentation of females and the elderly with type 1 diabetes in clinical exercise trials: A call to action.
   Diabet Med. 2026 Sep 4:e70468. doi: 10.1111/dme.70468.
   

   >> Share

   
   
9. FIELDEN J, Leblanc P, Parezanovic C, Sridhar VS, et al
   Participant and physician perspectives on the use of SGLT2 inhibitors in type 1 diabetes.
   Diabet Med. 2026 Sep 4:e70463. doi: 10.1111/dme.70463.
   

   >> Share

   
   

   
   Diabetes

10. CHEN ZZ, Mi MY, Barber J, Tiwari G, et al
    Longitudinal Repeated Protein Measurements in a Multiethnic Cohort Identify Novel Diabetes Biomarkers That Reveal Unique Disease Pathways.
    Diabetes. 2026 Sep 8:db260148. doi: 10.2337/db26-0148.
    

    >> Share

    
    

    
    Diabetes Care

11. HURLEY RW, Siraj ES, Sills S, Engle M, et al
    Evaluating Improvement in Pain and Sensory Function When Using High-Frequency (10-kHz) Spinal Cord Stimulation in Individuals With Painful Diabetic Neuropathy: A Multicenter Randomized Controlled Trial (PDN-Sensory).
    Diabetes Care. 2026 Sep 9:dc260758. doi: 10.2337/dc26-0758.
    

    >> Share

    
    

    
    Diabetes Obes Metab

12. KATZ A, Shulkin A, Jacobson S, Price C, et al
    Antenatal Corticosteroids in Gestational Diabetes: A Systematic Review of Glycemic Response and Management Strategies.
    Diabetes Obes Metab. 2026 Sep 9. doi: 10.1111/dom.71311.
    

    >> Share

    
    
13. SAKAI T, Ishibashi R, Koshizaka M, Takatsuna Y, et al
    Renal Safety of Intravitreal Ranibizumab and the Effects of SGLT2 Inhibition in Diabetic Macular Oedema: A Post Hoc Analysis of the COMET Trial.
    Diabetes Obes Metab. 2026 Sep 9. doi: 10.1111/dom.71314.
    

    >> Share

    
    
14. WELLENS-MENSAH J, Konantambigi A, Lopez K, Triay J, et al
    Dose-Normalised Time in Range (dn-TIR) Improves Following Hybrid Closed-Loop (HCL) Therapy in Type 1 Diabetes: A Real-World Cohort Study From Australia and the United Kingdom.
    Diabetes Obes Metab. 2026 Sep 9. doi: 10.1111/dom.71342.
    

    >> Share

    
    
15. LEE O, Son Y, Lopez-Gil JF, Rahmati M, et al
    Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists as Adjuncts to Insulin Therapy in Type 1 Diabetes Mellitus: An Overlap-Informed Umbrella Review.
    Diabetes Obes Metab. 2026 Sep 10. doi: 10.1111/dom.71325.
    

    >> Share

    
    
16. GONCALVES S, Ponchateau C, Coelho C, Pretre L, et al
    Real-World Adoption of Generative AI for Carbohydrate Counting in Adults With Type 1 Diabetes.
    Diabetes Obes Metab. 2026 Sep 9. doi: 10.1111/dom.71309.
    

    >> Share

    
    
17. FAN Y, Peng N, Jiang L, Wei R, et al
    Association of GLP-1 Receptor Agonists Versus Other Antidiabetic Medications With Cardiovascular, Renal, and Liver Outcomes in Patients With Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Sep 8. doi: 10.1111/dom.71313.
    

    >> Share

    
    
18. EPHRAUMS LA, Mignone ER, Lange K, Routley A, et al
    Glucagon-Like Peptide-1 Receptor Agonist Use Is Associated With Improved Lung Function in Cystic Fibrosis-Related Diabetes.
    Diabetes Obes Metab. 2026 Sep 8. doi: 10.1111/dom.71312.
    

    >> Share

    
    
19. XIN X, Zhang K, Yu W, Liu J, et al
    Metformin Use and Risk of Incident Hearing Loss Among Participants With Diabetes: A UK Biobank Cohort Study.
    Diabetes Obes Metab. 2026 Sep 8. doi: 10.1111/dom.71306.
    

    >> Share

    
    
20. TOH DJC, Hulikere S, Mufti R, Masoud M, et al
    A Multicentre Study of Prevalence and Risk Factors of Diabetic Retinopathy in Children and Young People With Type 1 Diabetes in the United Kingdom.
    Diabetes Obes Metab. 2026 Sep 8. doi: 10.1111/dom.71316.
    

    >> Share

    
    
21. GUO L, Li G, Chen X, Chen S, et al
    Prevalence and Incidence of Hypoglycaemia Among Patients With Type 2 Diabetes in China-A Prospective Cohort Study.
    Diabetes Obes Metab. 2026 Sep 8. doi: 10.1111/dom.71296.
    

    >> Share

    
    
22. RETNAKARAN R, Shen J, Hung RJ, Micklesfield LK, et al
    Dual Energy X-Ray Absorptiometry Reveals Differential Glycemic Implications of Adiposity in Underweight, Normal Weight, and Overweight South African Women With Newly-Diagnosed Diabetes.
    Diabetes Obes Metab. 2026 Sep 8. doi: 10.1111/dom.71333.
    

    >> Share

    
    

    
    Diabetologia

23. WEISS A, Huber E, Reinmuller F, Munzinger A, et al
    Continuous glucose monitoring using the FreeStyle Libre Pro iQ in presymptomatic type 1 diabetes.
    Diabetologia. 2026 Sep 7. doi: 10.1007/s00125-026-06852.
    

    >> Share

    
    
24. FUZAK NUNZIATO M, Yan B, Schliep KC, Farland LV, et al
    Correction: Endometriosis subtypes and risk of type 2 diabetes: the Advancing Research on Cardiovascular Health and Endometriosis Study (ARCHES) retrospective cohort study.
    Diabetologia. 2026 Sep 8. doi: 10.1007/s00125-026-06864.
    

    >> Share

    
    
25. SLOAN G, Anton A, Teh K, Caunt S, et al
    Thalamic neuronal and bioenergetic function in painful diabetic peripheral neuropathy: a dual magnetic resonance spectroscopy study.
    Diabetologia. 2026 Sep 10. doi: 10.1007/s00125-026-06846.
    

    >> Share

    
    
26. HEROLD KC, Dayan CM, Chatenoud L, Gitelman SE, et al
    Preserving beta cell function in children and adolescents with newly diagnosed stage 3 type 1 diabetes: per-protocol population analysis from the PROTECT randomised trial.
    Diabetologia. 2026 Sep 10. doi: 10.1007/s00125-026-06849.
    

    >> Share

    
    
27. ZIEGLER AG, Rewers MJ, Achenbach P, Bell KJ, et al
    International consensus guidance for general population screening for islet autoantibodies to diagnose early-stage type 1 diabetes: a nominal group technique process.
    Diabetologia. 2026 Sep 10. doi: 10.1007/s00125-026-06841.
    

    >> Share

    
    
28. SCHIPPER SBJ, Karagiannis T, Zaccardi F, Remmelzwaal S, et al
    Interventions to reduce diabetes-related distress among adults with type 1 or type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials.
    Diabetologia. 2026 Sep 11. doi: 10.1007/s00125-026-06789.
    

    >> Share

    
    

    
    Eur J Endocrinol

29. WANG J, Cooper J, Hathaway E, Singh M, et al
    SGLT-2 inhibitors and risk of 59 long-term health conditions, hospitalization, and mortality.
    Eur J Endocrinol. 2026;195:406-420.
    

    >> Share

    
    

    
    Invest Ophthalmol Vis Sci

30. HUA X, Hormel TT, Wang J, Flaxel CJ, et al
    Structural and Angiographic Assessment of the Nerve Fiber Layer in Age-Related Macular Degeneration and Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2026;67:17.
    

    >> Share

    
    

    
    J Am Coll Cardiol

31. MISRA A, Jowell A, Haidermota S, Perez E, et al
    Development and Validation of a Clinical Polygenic Risk Report in U.S.-Based Health Systems for 8 Cardiovascular Conditions.
    J Am Coll Cardiol. 2026 Apr 29:S0735-1097(26)05809.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

32. TAN L, Cooper JM, Gokhale K, Sainsbury C, et al
    Associations between fenofibrate use and sight-threatening diabetic retinopathy in type 2 diabetes: UK real-world evidence.
    J Clin Endocrinol Metab. 2026 Sep 7:dgag367. doi: 10.1210.
    

    >> Share

    
    
33. KAEGI-BRAUN N, Soderstrom Shields E, Ersson M, Strandberg R, et al
    Social inequalities in gestational diabetes prevalence and complication burden: a nationwide Swedish cohort study.
    J Clin Endocrinol Metab. 2026 Sep 7:dgag366. doi: 10.1210.
    

    >> Share

    
    
34. TRIOLO TM, Eaton AA, Chen WM, Witkowski P, et al
    Diabetes related genetics and outcomes after total pancreatectomy with islet autotransplantation.
    J Clin Endocrinol Metab. 2026 Sep 11:dgag355. doi: 10.1210.
    

    >> Share

    
    

    
    J Diabetes Complications

35. JOHNSON A, Straton E, Maya G, White S, et al
    The role of CGM sensor wear-time on the relationship between time-in-range and HbA1c.
    J Diabetes Complications. 2026;40:109378.
    

    >> Share

    
    
36. MOCKING D, Soedamah-Muthu SS, Nefs G, Holmes-Truscott E, et al
    The associations between different types of diabetes neuropathy symptoms and neuropathy-specific quality of life: Results from the diabetes MILES the Netherlands study.
    J Diabetes Complications. 2026;40:109398.
    

    >> Share

    
    

    
    Med Care

37. LEONARD T, Bowen ME, Billig JI, Gunasekaran U, et al
    Housing Wealth and Glycemic Control Among Patients With Type 2 Diabetes.
    Med Care. 2026;64:670-677.
    

    >> Share

    
    

    
    Metabolism

38. UNNIKRISHNAN R, Baskar V, Anjana RM, Mohan V, et al
    Prevention of type 2 diabetes in India and China.
    Metabolism. 2026;184:156761.
    

    >> Share

    
    

    
    Nature

39. GUAN N, Kong D, Gao X, Niu L, et al
    Glucose-responsive probiotics for glycaemic modulation in mice and monkeys.
    Nature. 2026;657:477-486.
    

    >> Share

    
    

    
    Ophthalmology

40. BISON HS, Zhu AS, Borissov M, Jung HJ, et al
    Association of Common Anti-Inflammatory Medications with Reduced Risk of Vision-Threatening Diabetic Retinopathy in Type 2 Diabetes.
    Ophthalmology. 2026 Sep 10:S0161-6420(26)00678.
    

    >> Share

    
    

    
    PLoS Med

41. LIANG KYH, Zheng TM, Tan D, Sasako T, et al
    Protein mediators of chronic kidney disease in Type 2 diabetes: A mendelian randomization study.
    PLoS Med. 2026;23:e1004802.
    

    >> Share

    
    

    
    PLoS One

42. GURGEL FESL, da Silva RM, Goncalves JL, do Nascimento CEM, et al
    Culturally grounded health communication to support self-care among pregnant women with diabetes: Development and content validation of an educational cordel in Brazil.
    PLoS One. 2026;21:e0357959.
    

    >> Share

    
    
43. SKORVANOVA M, Verespejova AI, Hanes J, Plasil R, et al
    Plasma neurofilament light chain in type 2 diabetes: Associations with diabetic peripheral neuropathy, age, and renal function in a pilot cross-sectional study.
    PLoS One. 2026;21:e0357207.
    

    >> Share

    
    
44. STAFNE SN, Rangul V, Dahle IA, Slapgaard LV, et al
    Device measured physical activity among women with and without adverse pregnancy outcomes: Data from the HUNT study.
    PLoS One. 2026;21:e0357050.
    

    >> Share

    
    
45. BERRY SA, Iqbal A, Elliott J, Gandhi R, et al
    Pain alleviation in diabetic neuropathy using hybrid closed loop insulin pumps (PAINLESS) - A randomised crossover trial protocol.
    PLoS One. 2026;21:e0357573.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share